Intellia Therapeutics
Ming Sun has extensive work experience in strategic sourcing. They currently hold the position of Director of Strategic Sourcing at Intellia Therapeutics, Inc. starting from October 2021. Prior to this, Ming worked at Biogen, where they held the roles of Associate Director of Strategic Sourcing from August 2017 to September 2021 and Senior Manager of Strategic Sourcing from June 2015 to August 2017. Ming also worked at Smith & Nephew as a Commodity Leader from September 2013 to May 2015, and at Cognex Corporation as a Sourcing Manager from September 2012 to September 2013.
Ming Sun holds a Bachelor's degree in Mechanical Engineering from Shanghai Jiao Tong University and a Master's degree in Engineering Management from Rose-Hulman Institute of Technology.
This person is not in the org chart
This person is not in any teams
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.